Needle in the Haystack, or Rembrandt in the Attic? Drug Repurposing's New Strategy
July 31st 2015Competitive pressures are driving more companies to repurpose APIs that had originally been developed for other indications. The industry has only "scratched the surface" of what might be possible, says consultant Hermann Mucke
Understanding the Extent of the Counterfeit and Substandard Drug Problem
July 14th 2015Important research is under way that will help us understand the extent of the presence of substandard, adulterated and counterfeit drugs around the world, and, thus, strengthen enforcement efforts and public outreach programs. Future studies will focus on the API and overall chemical content
QbD and PAT: A Marriage Made in Heaven?
May 11th 2015The basic principle behind QbD is that quality should be built into a product with an understanding of the product and process by which it is developed and manufactured along with a knowledge of the risks involved in manufacturing the product and how best to mitigate those risks.